Zobrazeno 1 - 10
of 11
pro vyhledávání: '"MESH: Immunization, Secondary"'
Autor:
Delphine Planas, Nell Saunders, Piet Maes, Florence Guivel-Benhassine, Cyril Planchais, Julian Buchrieser, William-Henry Bolland, Françoise Porrot, Isabelle Staropoli, Frederic Lemoine, Hélène Péré, David Veyer, Julien Puech, Julien Rodary, Guy Baele, Simon Dellicour, Joren Raymenants, Sarah Gorissen, Caspar Geenen, Bert Vanmechelen, Tony Wawina-Bokalanga, Joan Martí-Carreras, Lize Cuypers, Aymeric Sève, Laurent Hocqueloux, Thierry Prazuck, Félix A. Rey, Etienne Simon-Loriere, Timothée Bruel, Hugo Mouquet, Emmanuel André, Olivier Schwartz
Publikováno v:
Nature
Nature, 2022, 602 (7898), pp.671-675. ⟨10.1038/s41586-021-04389-z⟩
Nature, Nature Publishing Group, 2022, 602 (7898), pp.671-675. ⟨10.1038/s41586-021-04389-z⟩
Nature, 2022, 602 (7898), pp.671-675. ⟨10.1038/s41586-021-04389-z⟩
Nature, Nature Publishing Group, 2022, 602 (7898), pp.671-675. ⟨10.1038/s41586-021-04389-z⟩
The SARS-CoV-2 Omicron variant was first identified in November 2021 in Botswana and South Africa1-3. It has since spread to many countries and is expected to rapidly become dominant worldwide. The lineage is characterized by the presence of around 3
Autor:
Frédéric Tangy, Thierry Huet, Pierre Langlade-Demoyen, Christelle Liard, Marion Julithe, Marie Escande, Chantal Combredet, Jessie Thalmensi, Simon Wain-Hobson, Elodie Pliquet, Claude Ruffié, Thomas Bestetti, Valérie Najburg
Publikováno v:
Cancer Immunology, Immunotherapy
Cancer Immunology, Immunotherapy, 2019, 68 (4), pp.533-544. ⟨10.1007/s00262-018-2272-3⟩
Cancer Immunology, Immunotherapy, Springer Verlag, 2019, 68 (4), pp.533-544. ⟨10.1007/s00262-018-2272-3⟩
Cancer Immunology, Immunotherapy, 2019, 68 (4), pp.533-544. ⟨10.1007/s00262-018-2272-3⟩
Cancer Immunology, Immunotherapy, Springer Verlag, 2019, 68 (4), pp.533-544. ⟨10.1007/s00262-018-2272-3⟩
International audience; Cancer immunotherapy is seeing an increasing focus on vaccination with tumor-associated antigens (TAAs). Human telomerase (hTERT) is a TAA expressed by most tumors to overcome telomere shortening. Tolerance to hTERT can be eas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f044afa53550131a805a172fa5811146
https://hal-pasteur.archives-ouvertes.fr/pasteur-03232227
https://hal-pasteur.archives-ouvertes.fr/pasteur-03232227
Autor:
Crabot, Doris
Publikováno v:
Médecine humaine et pathologie. 2015
Pertussis is a bacterial disease, benign in adults, but with a high morbidity and mortality index in newborn infants. Early diagnosis and treatment, using appropriate antibiotics and hospital care, enabled to reduce the seriousness of the disease. Ho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::cb149bc0a333e6889966a3960ec5cf1c
https://dumas.ccsd.cnrs.fr/dumas-01305973
https://dumas.ccsd.cnrs.fr/dumas-01305973
Publikováno v:
Parasite Immunology
Parasite Immunology, Wiley, 2011, 33 (11), pp.594-608. ⟨10.1111/j.1365-3024.2011.01331.x⟩
Parasite Immunology, Wiley, 2011, 33 (11), pp.594-608. ⟨10.1111/j.1365-3024.2011.01331.x.⟩
Parasite Immunology, Wiley, 2011, 33 (11), pp.594-608. ⟨10.1111/j.1365-3024.2011.01331.x⟩
Parasite Immunology, Wiley, 2011, 33 (11), pp.594-608. ⟨10.1111/j.1365-3024.2011.01331.x.⟩
International audience; Carboxy-terminus of merozoite surface protein-1 (MSP-1(19) ) is the major protein on the surface of the plasmodial merozoite that acts as one of the most important blood-stage vaccine candidates. The present investigation was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::4b166a66fd9c10e29e658df3c88f6155
https://hal-riip.archives-ouvertes.fr/pasteur-00751829/document
https://hal-riip.archives-ouvertes.fr/pasteur-00751829/document
Autor:
Taravat Bamdad, Farzaneh Sabahi, Hamidreza Hashemi, Masume Tavasoti Kheiri, Abbas Jamali, Fereidoun Mahboudi
Publikováno v:
Clinical and Vaccine Immunology
Clinical and Vaccine Immunology, American Society for Microbiology, 2010, 17 (4), pp.683-7. ⟨10.1128/CVI.00445-09⟩
Clinical and Vaccine Immunology, American Society for Microbiology, 2010, 17 (4), pp.683-7. ⟨10.1128/CVI.00445-09⟩
Influenza virus infections cause yearly epidemics and are a major cause of lower respiratory tract illnesses in humans worldwide. Influenza virus has long been recognized to be associated with higher morbidity and mortality in diabetic patients. Vacc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90b1798dfd96daf43470af5d95e9cee9
https://hal-riip.archives-ouvertes.fr/pasteur-00746986/file/DNAvaccine_article_Clin._Vaccine_Immunol.pdf
https://hal-riip.archives-ouvertes.fr/pasteur-00746986/file/DNAvaccine_article_Clin._Vaccine_Immunol.pdf
Autor:
Farzin Roohvand, Arash Memarnejadian
Publikováno v:
Cellular Immunology
Cellular Immunology, Elsevier, 2010, 261 (2), pp.93-8. ⟨10.1016/j.cellimm.2009.11.005⟩
Cellular Immunology, Elsevier, 2010, 261 (2), pp.93-8. ⟨10.1016/j.cellimm.2009.11.005⟩
International audience; Correlation of hepatitis C virus (HCV) spontaneous resolution with Th1 and CD8(+)CTL responses during natural infection implies the potentiality of poly-CTL-epitopic HCV vaccines. We recently reported in silico design and cons
Autor:
Michelle Rémond, Véronique Béven, Daniel Dory, Roland Cariolet, André Jestin, Stéphan Zientara
Publikováno v:
Antiviral Research
Antiviral Research, Elsevier Masson, 2009, 83 (1), pp.45-52. ⟨10.1016/j.antiviral.2009.03.004⟩
Antiviral Research, Elsevier Masson, 2009, 83 (1), pp.45-52. ⟨10.1016/j.antiviral.2009.03.004⟩
International audience; DNA vaccination against Foot-and-Mouth Disease Virus (FMDV) is an attractive and alternative strategy to the use of classical inactivated viral vaccines. The injection of a pcDNA3.1-based DNA vaccine encoding for FMDV P1-2A3C3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e8d071f5fa482eb32ff39ddc19cdc6a
https://hal-anses.archives-ouvertes.fr/hal-00404759/file/Dory_D_et_al-AVR_2009_83_45-52_pre-print.pdf
https://hal-anses.archives-ouvertes.fr/hal-00404759/file/Dory_D_et_al-AVR_2009_83_45-52_pre-print.pdf
Autor:
Daniel Dory, André Jestin, Stéphan Zientara, Roland Cariolet, Michelle Rémond, Véronique Béven, Marija Backovic
Publikováno v:
Antiviral Research
Antiviral Research, Elsevier Masson, 2009, 81 (3), pp.217-25. ⟨10.1016/j.antiviral.2008.11.005⟩
Antiviral Research, 2009, 81 (3), pp.217-25. ⟨10.1016/j.antiviral.2008.11.005⟩
Antiviral Research, Elsevier Masson, 2009, 81 (3), pp.217-25. ⟨10.1016/j.antiviral.2008.11.005⟩
Antiviral Research, 2009, 81 (3), pp.217-25. ⟨10.1016/j.antiviral.2008.11.005⟩
International audience; To evaluate the feasibility of using pseudorabies virus (PrV) glycoprotein B (gB) as a carrier of foot and mouth disease virus (FMDV) antigens in DNA immunization, FMDV B- and T-cell epitopes were inserted either between the t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d73dcc6291bcdefcef1d8bac48a0740f
https://hal-anses.archives-ouvertes.fr/hal-00404242/document
https://hal-anses.archives-ouvertes.fr/hal-00404242/document
Autor:
Anna Kostrzak, Denise Guetard, Susanna Celli, Raffaella Greco, Monica Sala, Pierre Langlade-Demoyen, Simon Wain-Hobson, Francesco Sala, Minerva Cervantes Gonzalez
Publikováno v:
Vaccine
Vaccine, Elsevier, 2008, 26 (35), pp.4477-85. ⟨10.1016/j.vaccine.2008.06.059⟩
Vaccine, 2008, 26 (35), pp.4477-85. ⟨10.1016/j.vaccine.2008.06.059⟩
Vaccine, Elsevier, 2008, 26 (35), pp.4477-85. ⟨10.1016/j.vaccine.2008.06.059⟩
Vaccine, 2008, 26 (35), pp.4477-85. ⟨10.1016/j.vaccine.2008.06.059⟩
International audience; Transgenic tobacco plants expressing a HIV-1 polyepitope associated with hepatitis B (HBV) virus-like particles (VLPs) were previously described. It is demonstrated here that oral administration of these transgenic plants to h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::053b34c800df689c573e0e010ca6cd53
https://hal-pasteur.archives-ouvertes.fr/pasteur-00363402
https://hal-pasteur.archives-ouvertes.fr/pasteur-00363402
Autor:
S. Chevallier, Elisabeth Njamkepo, Véronique Abitbol, Fred Zepp, C.U. Meyer, Nicole Guiso, F. Vié le Sage, N. Clyti
Publikováno v:
Vaccine
Vaccine, 2007, 25 (8), pp.1390-7. ⟨10.1016/j.vaccine.2006.10.048⟩
Vaccine, Elsevier, 2007, 25 (8), pp.1390-7. ⟨10.1016/j.vaccine.2006.10.048⟩
Vaccine, 2007, 25 (8), pp.1390-7. ⟨10.1016/j.vaccine.2006.10.048⟩
Vaccine, Elsevier, 2007, 25 (8), pp.1390-7. ⟨10.1016/j.vaccine.2006.10.048⟩
Humoral and cell-mediated immune responses (CMI) were evaluated in subjects 3 and 6 years after primary and booster vaccination with either three-component acellular (Pa) or whole-cell (Pw) vaccines. Low anti-pertussis toxin (PT) antibody levels conf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c26758c0af73ffaf7cb76d30679df79c
https://hal-pasteur.archives-ouvertes.fr/pasteur-00169340
https://hal-pasteur.archives-ouvertes.fr/pasteur-00169340